Maternal and Perinatal Outcomes Associated With Extremely High Values for the sFlt‐1 (Soluble fms‐Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio

Maternal and Perinatal Outcomes Associated With Extremely High Values for the sFlt‐1 (Soluble fms‐Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio

Background There is little knowledge about the significance of extremely high values (>655) for the ratio of sFlt‐1 (soluble fms‐like tyrosine kinase 1) to PlGF (placental growth factor). We aim to describe the time‐to‐delivery interval and maternal and perinatal outcomes when such values are dem...

Full description

Bibliographic Details
Main Authors:	Cecilia Villalaín, Ignacio Herraiz, Leonor Valle, Manel Mendoza, Juan Luis Delgado, María Vázquez‐Fernández, Juan Martínez‐Uriarte, Íñigo Melchor, Sara Caamiña, Antoni Fernández‐Oliva, Olga Patricia Villar, Alberto Galindo
Format:	Article
Language:	English
Published:	Wiley 2020-04-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	fetal growth restriction placental dysfunction placental growth factor preeclampsia sFlt1
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.119.015548

Similar Items

Reduced expression in preterm birth of sFLT-1 and PlGF with a high sFLT-1/PlGF ratio in extracellular vesicles suggests a potential biomarker
by: Sama Hussein, et al.
Published: (2022-12-01)

sFlt-1, PlGF, sFlt-1/PlGF ratio and uterine artery Doppler for preeclampsia diagnostics
by: Viktorija Tarasevičienė, et al.
Published: (2016-01-01)

Correlation of sFlt/PlGF ratio with severity of preeclampsia in an Indian populationAJOG Global Reports at a Glance
by: Namrata Kumar, MD, MRCOG, EFOG, FACOG, et al.
Published: (2023-05-01)

sFLT1, PlGF, the sFLT1/PlGF Ratio and Their Association with Pre-Eclampsia in Twin Pregnancies—A Review of the Literature
by: Ioakeim Sapantzoglou, et al.
Published: (2023-06-01)

The sFlt-1/PlGF Ratio in Pregnant Patients Affected by COVID-19
by: Katarzyna Kosinska-Kaczynska, et al.
Published: (2023-01-01)

A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia
by: Vivek Pant, et al.
Published: (2019-07-01)

The sFlt-1/PlGF Ratio at 12, 24, and 32 Weeks Gestation in Twin Pregnancies as a Predictor of Placental Dysfunction
by: Elena Satorres-Pérez, et al.
Published: (2024-03-01)

Efficiency of sFlt-1/PlGF Ratio in Preeclampsia Diagnosis
by: Anca-Florina Tataru-Copos, et al.
Published: (2022-09-01)

Increased placental sFlt-1 but unchanged PlGF expression in late-onset preeclampsia
by: Laura Ehrlich, et al.
Published: (2017-04-01)

Predicting Time to Delivery in Hypertensive Disorders: Assessing PlGF and sFlt-1 with the Novel Parameter ‘Mtp-Multiples of a Normal Term Placenta’
by: Valentina Giardini, et al.
Published: (2024-03-01)

Correlation between uterine artery Doppler and the sFlt-1/PlGF ratio in different phenotypes of placental dysfunction
by: Vesna Fabjan-Vodusek, et al.
Published: (2019-01-01)

The Impact of Increased Maternal sFlt-1/PlGF Ratio on Motor Outcome of Preterm Infants
by: Lisa Middendorf, et al.
Published: (2022-06-01)

sFlt-1/PlGF Ratio in Prediction of Short-Term Neonatal Outcome of Small for Gestational Age Neonates
by: Jacek Witwicki, et al.
Published: (2021-08-01)

sFlt-1, Not PlGF, Is Related to Twin Gestation Choronicity in the First and Third Trimesters of Pregnancy
by: Szymon Kozłowski, et al.
Published: (2021-06-01)

Angiogenic factors (sFlt-1, PlGF) in twin pregnancy with placentaassociated complications
by: M. A. Kurtser, et al.
Published: (2022-11-01)

The role of sFlt1/PlGF ratio in the assessment of preeclampsia and pregnancy-related hypertensive disorders
by: Jonathan Baert, et al.
Published: (2021-07-01)

Progesterone Induced Blocking Factor Reduces Hypertension and Placental Mitochondrial Dysfunction in Response to sFlt-1 during Pregnancy
by: Evangeline Deer, et al.
Published: (2021-10-01)

Placental expression of sFlt-1 and PlGF in early preeclampsia vs. early IUGR vs. age-matched healthy pregnancies
by: Alice Hoeller, et al.
Published: (2017-04-01)

Trophoblast-Targeted Nanomedicine Modulates Placental sFLT1 for Preeclampsia Treatment
by: Lei Li, et al.
Published: (2020-02-01)

Predictive value of the sFlt-1/PlGF ratio for preeclampsia in twin pregnancies: a retrospective study
by: Satoshi Shinohara, et al.
Published: (2021-10-01)

Values of serum sFlt-1, PLGF levels, and sFlt-1/PLGF ratio in diagnosis and prognosis evaluation of preeclamptic patients
by: Xiaohe Zhu, et al.
Published: (2020-10-01)

sFlT-1/PlGF ratio as a predictor of preeclampsia in COVID-19 pregnant patients
by: Kamil Pluta, et al.
Published: (2024-01-01)

Enhanced Serum Levels of sFlt1: Impact on Materno–Fetal CMV Transmission
by: Lukas Penka, et al.
Published: (2020-04-01)

The Current Role of the sFlt-1/PlGF Ratio and the Uterine–Umbilical–Cerebral Doppler Ultrasound in Predicting and Monitoring Hypertensive Disorders of Pregnancy: An Update with a Review of the Literature
by: Cristian Nicolae Chirilă, et al.
Published: (2023-08-01)

Predictive Model for Preeclampsia Combining sFlt-1, PlGF, NT-proBNP, and Uric Acid as Biomarkers
by: Carmen Garrido-Giménez, et al.
Published: (2023-01-01)

Letter to the Editor: SFlt-1 and PlGF Levels in Pregnancies Complicated by SARS-CoV-2 Infection
by: Valentina Giardini, et al.
Published: (2021-11-01)

Higher daytime systolic BP, prepregnancy BMI and an elevated sFlt-1/PlGF ratio predict the development of hypertension in normotensive pregnant women
by: Almudena Lara-Barea, et al.
Published: (2022-12-01)

Human Placental NADPH Oxidase Mediates sFlt-1 and PlGF Secretion in Early Pregnancy: Exploration of the TGF-β1/p38 MAPK Pathways
by: Isabelle Hernandez, et al.
Published: (2021-02-01)

Literature Review: The sFlt1/PlGF Ratio and Pregestational Maternal Comorbidities: New Risk Factors to Predict Pre-Eclampsia
by: Nataliia Sergeevna Karpova, et al.
Published: (2023-04-01)

Clinical value and cost analysis of the sFlt-1/PlGF ratio in addition to the spot urine protein/creatinine ratio in women with suspected pre-eclampsia: PREPARE cohort study
by: M. Wind, et al.
Published: (2022-12-01)

Associations between Maternal sFlt-1/PlGF Ratio and Perinatal and Neonatal Outcomes in Newborns Born to Mothers with Preeclampsia
by: Hyo Ju Yang, et al.
Published: (2023-08-01)

Nested Case–Control Study of Corin Combined with sFlt-1/PLGF in Predicting the Risk of Preeclampsia
by: Liu M, et al.
Published: (2021-06-01)

Reduced fetal movement intervention Trial-2 (ReMIT-2): protocol for a pilot randomised controlled trial of standard care informed by the result of a placental growth factor (PlGF) blood test versus standard care alone in women presenting with reduced fetal movement at or after 36+ 0 weeks gestation
by: Lindsay Armstrong-Buisseret, et al.
Published: (2018-10-01)

sFlt-1 in Chronic Kidney Disease: Friend or Foe?
by: Masaru Matsui, et al.
Published: (2022-11-01)

Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix
by: Kyle H. Moore, et al.
Published: (2020-06-01)

Overexpression of Human sFLT1 in the Spongiotrophoblast Is Sufficient to Induce Placental Dysfunction and Fetal Growth Restriction in Transgenic Mice
by: Rebekka Vogtmann, et al.
Published: (2024-02-01)

Intraperitoneal Injection of High Tumor Necrosis Factor (TNF- α ) Serum Increase Soluble Fms-like Tyrosine Kinase 1 (sFlt-1) and Blood Pressure of Pregnant Mice
by: Bramantyo Aji Wicaksono, et al.
Published: (2015-05-01)

Predictive Value Analysis of Serum sFlt-1 and PLGF Levels/Ratio in Preeclampsia
by: Shuyuan Xue, et al.
Published: (2022-09-01)

Novel Ratio Soluble Fms-like Tyrosine Kinase-1/Angiotensin-II (sFlt-1/ANG-II) in Pregnant Women Is Associated with Critical Illness in COVID-19
by: Salvador Espino-y-Sosa, et al.
Published: (2021-09-01)

Activation of PAR-1/NADPH Oxidase/ROS Signaling Pathways is Crucial for the Thrombin-Induced sFlt-1 Production in Extravillous Trophoblasts: Possible Involvement in the Pathogenesis of Preeclampsia
by: Qi-tao Huang, et al.
Published: (2015-03-01)